Third Point takes 5.8% of Strata Critical Medical for $24.5m and says the company should explore a sale

Third Point LLC has disclosed a 5.8% stake in Strata Critical Medical, Inc. (CIK 1779128), the successor to Blade Air Mobility, Inc., and says the company should explore strategic alternatives including a potential sale (Schedule 13D, filed 15 October 2026).

The filing reports beneficial ownership of 5,126,511 shares, held with shared voting and dispositive power, as of an event date of 13 October 2026. The percentage is based on 88,466,806 shares outstanding as of 28 July 2026, as stated in the company's 10-Q filed on 4 August 2026 (Schedule 13D, filed 15 October 2026).

Third Point's funds paid an aggregate $24,452,374 for the shares, using their own investment capital (Schedule 13D, Item 3).

The filing says the shares were acquired for investment purposes. It describes the business as strong but not of a scale to support its current overhead, and says the company should explore strategic alternatives, including a potential sale managed by a reputable investment banking firm (Schedule 13D, Item 4).

The filing also states that management incentive options are not aligned with creating shareholder value, and that the reporting persons may communicate with management and the board about these matters (Schedule 13D, Item 4).

No board nominations or agreements with management are disclosed. The only arrangements listed are a joint filing agreement and a power of attorney (Schedule 13D, Item 6).

The filings do not state whether Third Point has proposed a buyer or an adviser, or whether the board has responded. Loro has made no approach to the company. Figures are as reported in Third Point's SEC filing.